MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune Medicine has built a differentiated discovery platform powered…
June 15, 2026 16:05 ET | Source: Adaptive Biotechnologies Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement…
April 15, 2026 16:05 ET | Source: Adaptive Biotechnologies SEATTLE, April 15, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:…
January 22, 2026 16:05 ET | Source: Adaptive Biotechnologies SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:…